[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 233 Reported in Senate (RS)]
<DOC>
Calendar No. 340
119th CONGRESS
2d Session
S. 233
[Report No. 119-111]
To amend the Office of National Drug Control Policy Reauthorization Act
of 2006 to modify the authority of the Office of National Drug Control
Policy with respect to the World Anti-Doping Agency, and for other
purposes.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
January 23, 2025
Mrs. Blackburn (for herself, Mr. Van Hollen, Mrs. Capito, Mr.
Blumenthal, Mr. Wicker, Ms. Blunt Rochester, and Mr. Lujan) introduced
the following bill; which was read twice and referred to the Committee
on Commerce, Science, and Transportation
February 23, 2026
Reported by Mr. Cruz, with an amendment
[Strike out all after the enacting clause and insert the part printed
in italic]
_______________________________________________________________________
A BILL
To amend the Office of National Drug Control Policy Reauthorization Act
of 2006 to modify the authority of the Office of National Drug Control
Policy with respect to the World Anti-Doping Agency, and for other
purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
<DELETED>SECTION 1. SHORT TITLE.</DELETED>
<DELETED> This Act may be cited as the ``Restoring Confidence in the
World Anti-Doping Agency Act of 2025''.</DELETED>
<DELETED>SEC. 2. AUTHORITY OF NATIONAL DRUG CONTROL POLICY WITH RESPECT
TO THE WORLD ANTI-DOPING AGENCY.</DELETED>
<DELETED> Section 701 of the Office of National Drug Control Policy
Reauthorization Act of 2006 (21 U.S.C. 2001) is amended--</DELETED>
<DELETED> (1) in subsection (a)--</DELETED>
<DELETED> (A) by amending paragraph (1) to read as
follows:</DELETED>
<DELETED> ``(1) United states olympic and paralympic
committee.--The term `United States Olympic and Paralympic
Committee' means the organization established by chapter 2205
of title 36, United States Code.'';</DELETED>
<DELETED> (B) in paragraph (3), by striking ``(36
U.S.C. 22501(b)(1))'' and inserting ``(36 U.S.C.
220501(b)(1))'';</DELETED>
<DELETED> (C) by redesignating paragraphs (1) and
(3) as paragraphs (4) and (1), respectively, and moving
the paragraphs so as to appear in numeric order;
and</DELETED>
<DELETED> (D) by inserting after paragraph (2) the
following:</DELETED>
<DELETED> ``(3) Independent athlete.--The term `independent
athlete' means an Olympic or Paralympic athlete who does not
serve, in any capacity--</DELETED>
<DELETED> ``(A) on the International Olympic
Committee;</DELETED>
<DELETED> ``(B) on the International Paralympic
Committee;</DELETED>
<DELETED> ``(C) at an international sports
federation recognized by the International Olympic
Committee or the International Paralympic
Committee;</DELETED>
<DELETED> ``(D) on the United States Olympic and
Paralympic Committee; or</DELETED>
<DELETED> ``(E) at the World Anti-Doping
Agency.'';</DELETED>
<DELETED> (2) in subsection (b)--</DELETED>
<DELETED> (A) by striking ``United States Olympic
Committee'' each place it appears and inserting
``United States Olympic and Paralympic
Committee'';</DELETED>
<DELETED> (B) in paragraph (5), by striking the
period at the end and inserting ``; and'';
and</DELETED>
<DELETED> (C) by adding at the end the
following:</DELETED>
<DELETED> ``(6) carry out responsibilities with respect to
the World Anti-Doping Agency, as described in subsection
(d).''; and</DELETED>
<DELETED> (3) by adding at the end the following:</DELETED>
<DELETED> ``(d) Authority With Respect to the World Anti-Doping
Agency.--</DELETED>
<DELETED> ``(1) In general.--The Office of National Drug
Control Policy, in consultation with the United States Anti-
Doping Agency, the United States Olympic and Paralympic
Committee, and the Team USA Athletes' Commission, shall--
</DELETED>
<DELETED> ``(A) use all available tools to ensure
that--</DELETED>
<DELETED> ``(i) the World Anti-Doping Agency
has a credible and independent governance model
that provides for fair representation of the
United States;</DELETED>
<DELETED> ``(ii) the World Anti-Doping
Agency fully implements all governance reforms,
including a proper conflict-of-interest policy
for all members of the Executive Committee, the
Foundation Board, and all relevant expert
advisory groups, standing committees, permanent
special committees, and working groups of the
World Anti-Doping Agency; and</DELETED>
<DELETED> ``(iii) independent athletes from
the United States and other democratic
countries, or representatives of such athletes,
have decision-making roles on the Executive
Committee and the Foundation Board, and in all
relevant expert advisory groups, standing
committees, permanent special committees, and
working groups, of the World Anti-Doping
Agency;</DELETED>
<DELETED> ``(B) demonstrate leadership within the
global community;</DELETED>
<DELETED> ``(C) have strict standards that work
toward countering doping in every form, including by
countering systemic fraud through doping involving--
</DELETED>
<DELETED> ``(i) governmental law
enforcement, intelligence, or anti-doping
institutions;</DELETED>
<DELETED> ``(ii) sporting organizations;
or</DELETED>
<DELETED> ``(iii) athlete support personnel;
and</DELETED>
<DELETED> ``(D) work collaboratively with democratic
countries.</DELETED>
<DELETED> ``(2) Determination.--</DELETED>
<DELETED> ``(A) In general.--Not later than 90 days
after the date of the enactment of this subsection, the
Office of National Drug Control Policy, in consultation
with the United States Anti-Doping Agency, the United
States Olympic and Paralympic Committee, and the Team
USA Athletes' Commission, shall make a determination as
to whether the World Anti-Doping Agency--</DELETED>
<DELETED> ``(i) has a credible and
independent governance model that provides for
fair representation of the United
States;</DELETED>
<DELETED> ``(ii) fully implements all
governance reforms, including a proper
conflict-of-interest policy described in
paragraph (1)(A)(ii); and</DELETED>
<DELETED> ``(iii) allows independent
athletes from the United States and other
democratic countries, or representatives of
such athletes, to have decision-making roles on
the Executive Committee and the Foundation
Board, and in all relevant expert advisory
groups, standing committees, permanent special
committees, and working groups, of the World
Anti-Doping Agency.</DELETED>
<DELETED> ``(B) Accountability.--In the case of a
determination under subparagraph (A) that the World
Anti-Doping Agency does not have such a governance
model, has not fully implemented such governance
reforms, or has not allowed decision-making roles
described in clause (iii) of that subparagraph, the
Office of National Drug Control Policy, in consultation
with the United States Anti-Doping Agency, the United
States Olympic and Paralympic Committee, and the Team
USA Athletes' Commission, shall--</DELETED>
<DELETED> ``(i) use all available tools to
ensure that the United States has fair
representation in the World Anti-Doping Agency,
including--</DELETED>
<DELETED> ``(I) on the Executive
Committee;</DELETED>
<DELETED> ``(II) on the Foundation
Board; and</DELETED>
<DELETED> ``(III) in all relevant
expert advisory groups, standing
committees, permanent special
committees, and working groups of the
World Anti-Doping Agency; and</DELETED>
<DELETED> ``(ii) not later than 180 days
after the date on which the determination under
subparagraph (A) is made, issue a report that
describes the barriers to participation and
fair representation of the United States on the
Executive Committee, the Foundation Board, and
all relevant expert advisory groups, standing
committees, permanent special committees, and
working groups of the World Anti-Doping
Agency.</DELETED>
<DELETED> ``(3) Voluntary nonpayment of dues.--</DELETED>
<DELETED> ``(A) In general.--In the case of a
determination under paragraph (2)(A) that the World
Anti-Doping Agency does not have a governance model
that provides for fair representation of the United
States, has not fully implemented governance reforms,
or has not allowed decision-making roles described in
clause (iii) of that subparagraph, the Office of
National Drug Control Policy, in consultation with the
appropriate committees of Congress, may voluntarily
withhold up to the full amount of membership dues to
the World Anti-Doping Agency.</DELETED>
<DELETED> ``(B) Appropriate committees of congress
defined.--In this paragraph, the term `appropriate
committees of Congress' means--</DELETED>
<DELETED> ``(i) the Subcommittee on Consumer
Protection, Product Safety, and Data Security
of the Committee on Commerce, Science, and
Transportation of the Senate (or a successor
subcommittee);</DELETED>
<DELETED> ``(ii) the Subcommittee on
Financial Services and General Government of
the Committee on Appropriations of the Senate
(or a successor subcommittee);</DELETED>
<DELETED> ``(iii) the Subcommittee on
Oversight and Investigations of the Committee
on Energy and Commerce of the House of
Representatives (or a successor subcommittee);
and</DELETED>
<DELETED> ``(iv) the Subcommittee on
Financial Services and General Government of
the Committee on Appropriations of the House of
Representatives (or a successor
subcommittee).</DELETED>
<DELETED> ``(4) Spending plan.--Not later than 30 days
before the Office of National Drug Control Policy obligates
funds to the World Anti-Doping Agency, the Office of National
Drug Control Policy shall submit to the Committee on
Appropriations of the Senate and the Committee on
Appropriations of the House of Representatives a spending plan
and explanation of proposed uses of such funds.''.</DELETED>
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Restoring Confidence in the World
Anti-Doping Agency Act of 2025''.
SEC. 2. AUTHORITY OF NATIONAL DRUG CONTROL POLICY WITH RESPECT TO THE
WORLD ANTI-DOPING AGENCY.
Section 701 of the Office of National Drug Control Policy
Reauthorization Act of 2006 (21 U.S.C. 2001) is amended--
(1) by striking subsection (a) and inserting the following:
``(a) Definitions.--In this subchapter:
``(1) Amateur athlete.--The term `amateur athlete' has the
meaning given that term in section 220501(b)(1) of title 36,
United States Code.
``(2) Amateur athletic competition.--The term `amateur
athletic competition' has the meaning given that term in
section 220501(b)(2) of title 36, United States Code.
``(3) Independent athlete.--The term `independent athlete'
means a current or former amateur athlete who does not serve,
in any capacity--
``(A) on the International Olympic Committee;
``(B) on the International Paralympic Committee;
``(C) at an international sports federation
recognized by the International Olympic Committee or
the International Paralympic Committee;
``(D) on the United States Olympic and Paralympic
Committee;
``(E) at a national governing body (as defined in
section 220501(b)(9) of title 36, United States Code);
or
``(F) at the World Anti-Doping Agency.
``(4) United states olympic and paralympic committee.--The
term `United States Olympic and Paralympic Committee' means the
organization established by chapter 2205 of title 36, United
States Code.'';
(2) in subsection (b), by striking ``United States Olympic
Committee'' each place it appears and inserting ``United States
Olympic and Paralympic Committee''; and
(3) by adding at the end the following:
``(d) Authority With Respect to the World Anti-Doping Agency.--
``(1) Annual determination.--Not later than 180 days after
the date of the enactment of this subsection, and annually
thereafter, the Office of National Drug Control Policy, in
consultation with the United States Anti-Doping Agency, the
United States Olympic and Paralympic Committee, and the
Athletes' Advisory Council (established and maintained under
section 220504(b)(2)(A) of title 36, United States Code) shall
make a determination as to whether the World Anti-Doping
Agency--
``(A) has a credible and independent governance
model that provides for fair representation of the
United States;
``(B) fully implements or has implemented
governance reforms to ensure independent governance;
and
``(C) has fair processes and procedures to select
independent athletes, including athletes from the
United States and other democratic countries, or
representatives of such athletes, for decision-making
roles on the Executive Committee and the Foundation
Board, and in all relevant expert advisory groups,
standing committees, permanent special committees, and
working groups of the World Anti-Doping Agency.
``(2) Accountability.--In the case of a determination under
paragraph (1) that the World Anti-Doping Agency has not met the
criteria set forth in subparagraphs (A), (B), or (C) of that
paragraph, the Office of National Drug Control Policy, in
consultation with the United States Anti-Doping Agency, the
United States Olympic and Paralympic Committee, and the
Athletes' Advisory Council (established and maintained under
section 220504(b)(2)(A) of title 36, United States Code), shall
use all available tools and best efforts to bring the World
Anti-Doping Agency into compliance with the criteria set forth
in that paragraph.
``(3) Report.--In the case of a determination under
paragraph (1) that the World Anti-Doping Agency has not met the
criteria set forth in subparagraphs (A), (B), or (C) of that
paragraph, not later than 180 days after the date on which that
determination is made, the Office of National Drug Control
Policy, in consultation with the United States Anti-Doping
Agency, the United States Olympic and Paralympic Committee, and
the Athletes' Advisory Council (established and maintained
under section 220504(b)(2)(A) of title 36, United States Code)
shall submit to the appropriate committees of Congress a report
that describes the barriers to participation and fair
representation of the United States on the Executive Committee,
the Foundation Board, and all relevant expert advisory groups,
standing